Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

completed250%
unknown250%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_4

Laser Ablation Versus Mechanochemical Ablation Trial

NCT02627846
unknown

PREservation Versus Thermal Ablation

NCT04034329
completednot_applicable

Mechanochemical Ablation vs Thermal Ablation

NCT03722134
unknownnot_applicable

RCT - Does Treating Incompetent Perforators Reduce Recurrence?

NCT01949207

Clinical Trials (4)

Showing 4 of 4 trials
NCT02627846Phase 4

Laser Ablation Versus Mechanochemical Ablation Trial

Completed
NCT04034329

PREservation Versus Thermal Ablation

Unknown
NCT03722134Not Applicable

Mechanochemical Ablation vs Thermal Ablation

Completed
NCT01949207Not Applicable

RCT - Does Treating Incompetent Perforators Reduce Recurrence?

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4